β Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (464) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due DiligenceποΈ SEC Filings
Date accepted | Link | Final link |
---|---|---|
2025-05-01 07:47:19 | 6-K | 6-K final |
2025-04-30 08:38:21 | 6-K | 6-K final |
2025-04-30 08:11:55 | 6-K | 6-K final |
2025-04-29 10:45:23 | 6-K | 6-K final |
2025-04-28 11:09:42 | 6-K | 6-K final |
2025-04-25 06:26:36 | ***** | ***** |
2025-04-24 06:30:53 | ***** | ***** |
2025-04-23 08:09:47 | ***** | ***** |
2025-04-22 06:22:13 | ***** | ***** |
2025-04-17 13:12:13 | ***** | ***** |
2025-04-17 11:48:02 | ***** | ***** |
2025-04-17 07:48:55 | ***** | ***** |
2025-04-17 07:38:21 | ***** | ***** |
2025-04-17 07:19:15 | ***** | ***** |
2025-04-16 06:29:47 | ***** | ***** |

π Explore more SEC filings for GlaxoSmithKline!
Sign up for free or log inπ₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"